Jakarta (Benchmark News) – The performance of shares of PT Bank Mandiri Tbk. are likely to be strengthened and the Middle test level 11,950.
PT Danareksa Securities analyst Lucky Bayu Purnomo projecting stock performance the highest target issuers, codenamed BMRI stock it at the price range Rp 12.150 per share.
According to him, the increase in the price of the stock price performance of the BMRI carries with BMRI which is above the average transaction for 20 day and 50 the previous day.
“The stock performance of the BMRI a likely to be strengthened,” she wrote in an e-mail on Tuesday (8/11/1999).
Previously, buy recommendation was submitted by stockshoot on June 28, 2016 at the price of 9,000 and sell recommendations on price performance growth with total 11,800 19% up to 10 August 2016 before.
Trading on Tuesday (8/12/2016) 15.25 am GMT, the share price is at a level of Rp BMRI 11.625 per share, or 250 points or 2.2%.
Bank Mandiri (Persero) records, scoring a net profit worth Rp12 trillion in the quarter III this year. When compared with the same period last year, the company’s net profit dropped by 17.6% from Rp14,6 trillion….(Red)